Ado-trastuzumab Emtansine

MAR 26, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Kadcyla (Labeling)

U.S. Food and Drug Administration

This is an FDA supplemental approval action for labeling of an already-approved drug; it documents a regulatory decision, not clinical trial evidence or efficacy data.